Epstein-Barr virus gp350-ferritin nanoparticle vaccine with saponin-based adjuvant

{
  "id": "MLC-T-ONC-013399",
  "term": "Epstein-Barr virus gp350-ferritin nanoparticle vaccine with saponin-based adjuvant",
  "field": "Oncology and biomedicine",
  "definition": "A ferritin-based, nanoparticle vaccine consisting of the Epstein-Barr Virus (EBV) envelop glycoprotein gp350 and a saponin-based adjuvant, with potential immunizing activity against EBV. Upon intramuscular administration of EBV gp350-ferritin nanoparticle vaccine with saponin-based adjuvant, the EBV gp350 may activate both humoral and cellular immune responses which may result in protection against EBV infection. EBV, a ubiquitous human herpes virus, is associated with infectious mononucleosis and various malignancies, including nasopharyngeal carcinoma, Hodgkin disease, non-Hodgkin lymphoma, and other lymphomas.",
  "synonyms": [
    "EBV gp350-based nanoparticles vaccine",
    "Epstein-Barr virus gp350-ferritin nanoparticle vaccine with matrix-M1 adjuvant",
    "EBV gp350-ferritin nanoparticle vaccine with saponin-based adjuvant",
    "EBV gp350-ferritin vaccine",
    "EBV gp350-based nanoparticle vaccine",
    "EBV gp350-ferritin vaccine/matrix M1"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/epstein-barr-virus-gp350-ferritin-nanoparticle-vaccine-with-saponin-based/"
}